INSIGHTS ON DRUG DEVELOPMENT
-
ITC For Binding Characterization In Pharmaceutical Research
Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.
-
Rethinking Starting Material: Whole Blood For Autologous T-Cell Manufacture
Matching starting material to process requirements in autologous T-cell manufacturing, and where whole blood may stand in for leukapheresis without compromising what the process needs.
-
The Importance Of Reliable Mixing In ITC Experiments
Explore how Isothermal Titration Calorimetry (ITC) precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new therapeutic strategies.
-
5 Key Considerations For Companies Outsourcing Process Development
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients1/7/2026
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Spray Drying: The Key To Maximize Drug Solubility And Bioavailability9/23/2026
Spray drying helps overcome formulation challenges by improving solubility, bioavailability, and particle performance for complex drug candidates.
-
Ask Us Anything: Eric Fang On New Challenges In Pharma Development7/24/2026
Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.
-
5 Hidden Risks In Early-Phase OSD Formulation Development8/31/2026
Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
DRUG DEVELOPMENT SOLUTIONS
-
Characterize Samples and Identify Unknown Components
Do you often need to identify unknown compounds from complex samples? ACD/MS Structure ID Suite offers a simple, replicable workflow for generating and narrowing down structural candidates.
- Deconvolute complex LC/MS and GC/MS data into individual component traces
- Search proprietary and commercial databases for spectral matches
- Search PubChem for accurate-mass and molecular-formula matches
- Narrow down candidate structures by retention time and fragment include/exclude lists
-
Precise optics, fluidic transfer, and assay flexibility on one integrated microplate reader.
-
Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.
-
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.